MAM
IMGN

Meeder Asset Management’s Immunogen Inc IMGN Stock Holding History

Meeder Asset Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-88
Closed -$1K – 2685
2021
Q2 		$1K Buy
+88
New +$614 ﹤0.01% 2427
2020
Q4 		– Sell
-5,459
Closed -$19K – 2307
2020
Q3 		$19K Sell
5,459
-7,076
-56% -$28.6K ﹤0.01% 1194
2020
Q2 		$58K Buy
12,535
+5,676
+83% +$24.1K ﹤0.01% 894
2020
Q1 		$21K Sell
6,859
-8,217
-55% -$35.9K ﹤0.01% 1234
2019
Q4 		$78K Buy
15,076
+8,365
+125% +$28.4K ﹤0.01% 880
2019
Q3 		$16K Buy
6,711
+6,027
+881% +$16K ﹤0.01% 1394
2019
Q2 		$1K Buy
+684
New +$1.62K ﹤0.01% 1993
2019
Q1 		– Sell
-939
Closed -$5K – 1908
2018
Q4 		$5K Sell
939
-299
-24% -$1.81K ﹤0.01% 1431
2018
Q3 		$11K Sell
1,238
-2,334
-65% -$22.4K ﹤0.01% 1147
2018
Q2 		$34.8K Buy
3,572
+1,256
+54% +$13.2K ﹤0.01% 845
2018
Q1 		$25K Buy
2,316
+2,286
+7,620% +$22.6K ﹤0.01% 837
2017
Q4 		$0 Sell
30
-405
-93% -$2.5K ﹤0.01% 1830
2017
Q3 		$3K Sell
435
-737
-63% -$4.9K ﹤0.01% 1398
2017
Q2 		$8K Sell
1,172
-5,607
-83% -$25.7K ﹤0.01% 1064
2017
Q1 		$26K Sell
6,779
-9,415
-58% -$27.5K ﹤0.01% 690
2016
Q4 		$33K Buy
+16,194
New +$32.5K ﹤0.01% 603

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Meeder Asset Management's IMGN Position: Q3 2021 in Review

Meeder Asset Management sold out of Immunogen Inc (IMGN) in Q3 2021, closing a stake of 88 shares — an estimated $1K sold.

Meeder Asset Management first reported a position in IMGN in Q4 2016 and held it in 16 quarters. The position peaked at $78K in Q4 2019. 217 funds tracked by Wall St. Rank hold IMGN as of Q3 2021.

  • Meeder Asset Management reported no remaining Immunogen Inc position as of Q3 2021 after selling out during the quarter.
  • Meeder Asset Management sold 88 Immunogen Inc shares in Q3 2021, an estimated $1K.
  • Meeder Asset Management first reported a position in Immunogen Inc in Q4 2016 and held it in 16 quarters.
  • Meeder Asset Management's Immunogen Inc position peaked at $78K in Q4 2019.
  • 217 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2021.

Based on Meeder Asset Management's 13F filing for Q3 2021, filed 8 Nov 2021.